Richards, S., Amaravadi, L., Pillutla, R., Birnboeck, H., Torri, A., Cowan, K. J., Papadimitriou, A., Garofolo, F., Satterwhite, C., Piccoli, S., Wu, B., Krinos-Fiorotti, C., Allinson, J., Berisha, F., Cocea, L., Croft, S., Fraser, S., Galliccia, F., Gorovits, B., Gupta, S., Gupta, V., Haidar, S., Hottenstein, C., Ishii-Watabe, A., Jani, D., Kadavil, J., Kamerud, J., Kramer, D., Litwin, V., Lima Santos, G. M., Nelson, R., Ni, Y., Pedras-Vasconcelos, J., Qiu, Y., Rhyne, P., Safavi, A., Saito, Y., Savoie, N., Scheibner, K., Schick, E., Siguenza, P. Y., Smeraglia, J., Staack, R. F., Subramanyam, M., Sumner, G., Thway, T., Uhlinger, D., Ullmann, M., Vitaliti, A., Welink, J., Whiting, C. C., Xue, L., & Zeng, R. (2016). 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 – LBA, biomarkers and immunogenicity). Bioanalysis, 8, 2475–2496. http://access.bl.uk/ark:/81055/vdc_100137419307.0x000003